MENS
Price
$2.03
Change
-$0.12 (-5.58%)
Updated
Sep 25 closing price
Capitalization
150.69M
Intraday BUY SELL Signals
TRAW
Price
$0.56
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
8.66M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MENS vs TRAW

MENS vs TRAW Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MENS vs. TRAW commentary
Sep 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MENS is a Hold and TRAW is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
TRAW: Fundamental Ratings
TRAW
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MENSTRAW
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
COMPARISON
Comparison
Sep 27, 2026
Stock price -- (MENS: $2.03 vs. TRAW: $0.56)
Brand notoriety: MENS and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MENS: 45% vs. TRAW: 66%
Market capitalization -- MENS: $150.69M vs. TRAW: $8.66M
MENS [@Biotechnology] is valued at $150.69M. TRAW’s [@Biotechnology] market capitalization is $8.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MENS’s FA Score shows that 1 FA rating(s) are green while TRAW’s FA Score has 1 green FA rating(s).

  • MENS’s FA Score: 1 green, 4 red.
  • TRAW’s FA Score: 1 green, 4 red.
According to our system of comparison, TRAW is a better buy in the long-term than MENS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MENS’s TA Score shows that 5 TA indicator(s) are bullish while TRAW’s TA Score has 6 bullish TA indicator(s).

  • MENS’s TA Score: 5 bullish, 5 bearish.
  • TRAW’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, TRAW is a better buy in the short-term than MENS.

Price Growth

MENS (@Biotechnology) experienced а -1.46% price change this week, while TRAW (@Biotechnology) price change was +14.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.17%. For the same industry, the average monthly price growth was -13.24%, and the average quarterly price growth was +5.35%.

Reported Earning Dates

TRAW is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MENS
Daily Signal:
Gain/Loss:
TRAW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SLYV103.990.41
+0.40%
State Street SPDR S&P 600 Small Cap Value ETF (SLYV)
QBUF31.150.07
+0.21%
Innovator Nasdaq-100 10 Buffer ETF Quarterly (QBUF)
BCGD26.310.05
+0.20%
Baron Global Durable Advantage ETF (BCGD)
GBND48.450.06
+0.13%
Goldman Sachs Core Bond ETF (GBND)
URE60.99-0.26
-0.43%
ProShares Ultra Real Estate (URE)

MENS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MENS has been loosely correlated with VTGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MENS jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MENS
1D Price
Change %
MENS100%
-5.58%
VTGN - MENS
58%
Loosely correlated
-7.46%
KYTX - MENS
37%
Loosely correlated
-2.58%
BNTC - MENS
28%
Poorly correlated
-0.52%
FDMT - MENS
27%
Poorly correlated
-1.63%
TRAW - MENS
27%
Poorly correlated
+0.57%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with SLGL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then SLGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
+0.57%
SLGL - TRAW
47%
Loosely correlated
+10.06%
MESO - TRAW
34%
Loosely correlated
-2.33%
ELTX - TRAW
32%
Poorly correlated
-2.13%
TAOX - TRAW
32%
Poorly correlated
-0.89%
AXON - TRAW
32%
Poorly correlated
-3.35%
More